ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2026
[Trends of disease burden on spinal cord injury in China from 1990 to 2023].
Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the epidemiological features and changing trends of disease burden of spinal cord injury (SCI) in China from 1990 to 2023, conduct decomposition analysis of disease burden changes, and provide evidence for SCI prevention and control. Methods: Based on the 2023 Global Burden of Disease (GBD) study data, indicators including incidence and years lived with disability (YLDs) were used to analyze the status and changing trends of SCI disease burden in China from 1990 to 2023. The Gupta decomposition framework was applied to quantify the contributions of population growth, population aging, age-specific incidence rate changes, and disease severity changes to YLDs growth. Results: In 2023, the number of SCI incidence cases in China was 232 700 cases, representing a 43.6% increase compared to 1990. From 1990 to 2023, the age-standardized YLDs rate of SCI decreased, while the age-standardized incidence rate showed an overall upward trend: it increased year by year from 1990 to 2015, declined briefly after 2015, and rose again from 2020. The disease burden of SCI in males was higher than in females. The age distribution of disease burden showed a shift toward older age groups, with incidence rates increasing with age among middle-aged and elderly populations. Falls were the main cause of SCI in China. Compared with 1990, YLDs in males and females increased by 48.58% and 41.72% respectively in 2023. The proportions of male growth attributed to population growth, population aging, age-specific incidence rate changes, and disease severity changes were 22.79%, 22.69%, 34.99%, and -31.88%, while those for females were 23.82%, 26.30%, 21.99%, and -30.40%. Conclusion: From 1990 to 2023, population aging made a substantial contribution to the growth of SCI disease burden in China. The primary factor driving the growth of SCI disease burden differed by gender. Clinical interventions that mitigate disease severity represent a key strategy for addressing the rapid growth of SCI disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.